Biotechnology
Unitedstates
Cancer
Therapy
Innovation
Discovery
Development
Pharmaceuticals
M&A Advisory
Lazard
Full Credential Description
SGX Pharmaceuticals. United States. Announced Date 20/11/2007. Closed Date 23/11/2007. Deal value: $25m. PIPE offering of common stock. Industry: SGX Pharmaceuticals is a biotechnology company focused on the discovery and development of innovative cancer therapies.